Bickling Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$308K Buy
6,013
+32
+0.5% +$1.53K 0.19% 85
2022
Q3
$262K Buy
5,981
+33
+0.6% +$1.6K 0.18% 91
2022
Q2
$312K Buy
5,948
+30
+0.5% +$1.53K 0.2% 87
2022
Q1
$306K Buy
5,918
+239
+4% +$12.4K 0.16% 99
2021
Q4
$335K Buy
5,679
+227
+4% +$11.2K 0.16% 95
2021
Q3
$235K Buy
5,452
+29
+0.5% +$1.28K 0.12% 108
2021
Q2
$212K Buy
+5,423
New +$211K 0.1% 126

Other funds holding PFE

Bickling Financial Services's PFE Position: Q4 2022 in Review

Bickling Financial Services increased its Pfizer (PFE) stake by 0.54% in Q4 2022, buying an estimated $1.53K and bringing the position to 6,013 shares worth $308K. The position accounts for 0.19% of the portfolio, ranked #85.

Bickling Financial Services first reported a position in PFE in Q2 2021 and has held it in 7 quarters since. The position peaked at $335K in Q4 2021. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Bickling Financial Services held 6,013 shares of Pfizer worth $308K as of Q4 2022.
  • Bickling Financial Services bought 32 Pfizer shares in Q4 2022, an estimated $1.53K.
  • Pfizer made up 0.19% of Bickling Financial Services's portfolio in Q4 2022, its #85 holding.
  • Bickling Financial Services first reported a position in Pfizer in Q2 2021 and has held it in 7 quarters since.
  • Bickling Financial Services's Pfizer position peaked at $335K in Q4 2021.
  • 3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.